RCI
Ridgeback Capital Investments Portfolio holdings
AUM
$560K
This Quarter Return
+3.48%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$79.1M
AUM Growth
–
Cap. Flow
+$79.1M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
5
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Sangamo Therapeutics
SGMO
|
$40.3M |
| 2 |
Celldex Therapeutics
CLDX
|
$24.8M |
| 3 |
STML
Stemline Therapeutics, Inc.
STML
|
$9.93M |
| 4 |
Arrowhead Research
ARWR
|
$3.03M |
| 5 |
Geron
GERN
|
$1.07M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Sangamo Therapeutics
SGMO
$163M
| $40.3M | 50.91% |
+2,900,000
| New | +$40.3M |
|
|
2
Celldex Therapeutics
CLDX
$1.57B
| $24.8M | 31.36% |
+1,025,000
| New | +$24.8M |
|
|
STML
3
DELISTED
Stemline Therapeutics, Inc.
STML
| $9.93M | 12.55% |
+506,699
| New | +$9.93M |
|
|
4
Arrowhead Research
ARWR
$3.77B
| $3.03M | 3.83% |
+279,361
| New | +$3.03M |
|
|
5
Geron
GERN
$900M
| $1.07M | 1.35% |
+225,000
| New | +$1.07M |
|